Related Experiment Video
Updated: Nov 1, 2025

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
PROGRESSION OF PARTIAL POSTERIOR VITREOUS DETACHMENT OVER TIME
Elizabeth C Koller1, Jessica A Kraker, Eileen S Hwang
1Department of Ophthalmology and Visual Sciences, The Eye Institute, Medical College of Wisconsin, Milwaukee, Wisconsin.
Individuals show significant variation in the progression of posterior vitreous detachment (PVD) and vitreomacular adhesion area (VMAA). While PVD stage varies, VMAA declines consistently in early stages.
Area of Science:
- Ophthalmology
- Retinal Science
- Vitreous Imaging
Background:
- Posterior vitreous detachment (PVD) and vitreomacular adhesion area (VMAA) change with age.
- Population-level data may obscure individual differences in PVD and VMAA progression.
Purpose of the Study:
- Investigate interindividual variability in the rate of PVD stage progression.
- Quantify changes in VMAA over time.
Main Methods:
- Retrospective analysis of optical coherence tomography (OCT) scans from asymptomatic eyes.
- Turnbull estimator for PVD stage modeling.
- Linear mixed models for VMAA change analysis.
Main Results:
- 101 eyes evaluated; 76% remained at the same PVD stage.
- Longitudinal modeling predicts variable age of complete PVD (Stage 4).
- VMAA decreased uniformly in early partial PVD (Stage 1) at an average of 0.13 mm²/year.
Conclusions:
- Significant interindividual differences exist in the age of PVD progression.
- VMAA exhibits a consistent rate of decline during early partial PVD.
More Related Videos
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
08:55Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
Published on: April 24, 2020
Related Concept Videos
Glaucoma: Overview
Photoreceptors and Visual Pathways
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...